We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
60 hedge funds and large institutions have $59.2M invested in Cardiff Oncology in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
220% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 10
63% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $1.27M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 66 → 60 (-6)
33% less capital invested
Capital invested by funds: $88.5M → $59.2M (-$29.2M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Holders
60
Holders Change
-6
Holders Change %
-9.09%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
32
Reduced
10
Closed
16
Calls
$2.08M
Puts
$1.27M
Net Calls
+$802K
Net Calls Change
+$1.73M
Top Buyers
Top Sellers
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$2.95M |
| 2 |
Renaissance Technologies
New York
|
-$1.34M |
| 3 |
Goldman Sachs
New York
|
-$1.18M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$1.08M |
| 5 |
FAM
Fred Alger Management
New York
|
-$671K |
